Rituximab use in children with complicated idiopathic nephrotic syndrome - a single centre experience
Background: In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission allowing steroids and calcineurin inhibitors taper. Methods: We retrospectively reviewed all children receiving rituximab for idiopathic nephrotic syndrome at a tertiary hospital. All patients, e...
Main Authors: | Carla Leal Moreira, Rita Baptista, Pedro Maneira Sousa, Juliana Maciel, Liane Costa, Ana Teixeira, Teresa Costa, Paula Matos, Liliana Rocha, Maria Sameiro Faria, Conceição Mota |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro Hospitalar do Porto
2019-07-01
|
Series: | Nascer e Crescer |
Subjects: | |
Online Access: | https://revistas.rcaap.pt/nascercrescer/article/view/15974 |
Similar Items
-
Rituximab in steroid resistant nephrotic syndrome
by: Agomoni Chaki, et al.
Published: (2019-07-01) -
Rituximab Use in the Management of Childhood Nephrotic Syndrome
by: Mahmoud Kallash, et al.
Published: (2019-05-01) -
Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
by: Rezan Topaloğlu, et al.
Published: (2019-07-01) -
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
by: Ryosuke Usui, et al.
Published: (2018-10-01) -
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
by: Biswanath Basu, et al.
Published: (2020-11-01)